share_log

Novavax | 4: Statement of changes in beneficial ownership of securities-Officer Trizzino John

Novavax | 4: Statement of changes in beneficial ownership of securities-Officer Trizzino John

諾瓦瓦克斯醫藥 | 4:持股變動聲明-高管 Trizzino John
SEC announcement ·  03/13 08:49
牛牛AI助理已提取核心訊息
John Trizzino, President and COO of Novavax Inc, completed a stock transaction on March 10, 2024. The transaction involved the sale of 2,226 shares of Novavax common stock at a price of $5.45 per share, resulting in a total market value of $12,131.70. Prior to this sale, Trizzino exercised options to acquire 4,608 shares of the company's stock. Following these transactions, Trizzino's direct holdings in Novavax amounted to 27,972 shares. The sale was conducted under a transaction code indicating the payment of exercise price or tax liability by delivering or withholding securities.
John Trizzino, President and COO of Novavax Inc, completed a stock transaction on March 10, 2024. The transaction involved the sale of 2,226 shares of Novavax common stock at a price of $5.45 per share, resulting in a total market value of $12,131.70. Prior to this sale, Trizzino exercised options to acquire 4,608 shares of the company's stock. Following these transactions, Trizzino's direct holdings in Novavax amounted to 27,972 shares. The sale was conducted under a transaction code indicating the payment of exercise price or tax liability by delivering or withholding securities.
Novavax Inc總裁兼首席運營官約翰·特里齊諾於2024年3月10日完成了股票交易。該交易涉及以每股5.45美元的價格出售2,226股Novavax普通股,總市值爲12,131.70美元。在此次出售之前,Trizzino行使了期權收購了該公司4,608股股票。這些交易之後,Trizzino在Novavax的直接持股量爲27,972股。此次出售是根據交易代碼進行的,該交易代碼表明通過交付或預扣證券來支付行使價或應納稅額。
Novavax Inc總裁兼首席運營官約翰·特里齊諾於2024年3月10日完成了股票交易。該交易涉及以每股5.45美元的價格出售2,226股Novavax普通股,總市值爲12,131.70美元。在此次出售之前,Trizzino行使了期權收購了該公司4,608股股票。這些交易之後,Trizzino在Novavax的直接持股量爲27,972股。此次出售是根據交易代碼進行的,該交易代碼表明通過交付或預扣證券來支付行使價或應納稅額。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。